While the broader stock market suffered steep losses on Friday amid trade policy shifts and troubling economic data, select health technology equities stood out.
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants J. Todd Koning - Executive VP & CFO Patrick S.
Alphatec (ATEC) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to a loss of $0.29 per share a year ago.
30 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
29 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
28 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
31 Jul 2025 Date | | - Cons. EPS | - EPS |
30 Jul 2025 Date | | - Cons. EPS | - EPS |
30 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
29 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
28 Oct 2025 (In 2 months) Date | | - Cons. EPS | - EPS |
31 Jul 2025 Date | | - Cons. EPS | - EPS |
30 Jul 2025 Date | | - Cons. EPS | - EPS |
Medical - Devices Industry | Healthcare Sector | Patrick S. Miles CEO | XBER Exchange | US02081G2012 ISIN |
US Country | 867 Employees | - Last Dividend | 25 Aug 2016 Last Split | 2 Jun 2006 IPO Date |
Alphatec Holdings, Inc., founded in 1990 and headquartered in Carlsbad, California, is a distinguished medical technology company focused on the design, development, and commercialization of innovative technologies for the surgical treatment of spinal disorders. Operating both in the United States and internationally, Alphatec manufactures and supplies its revolutionary products through a combination of third-party suppliers, independent sales agents, and direct sales representatives. The company's commitment to advancing spinal surgery technologies has positioned it as a leader in its field, offering a wide range of solutions aimed at improving patient outcomes.